Aehr Test Systems (NASDAQ:AEHR) Shares Gap Up – Should You Buy?

Aehr Test Systems (NASDAQ:AEHRGet Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $72.01, but opened at $98.16. Aehr Test Systems shares last traded at $98.61, with a volume of 4,180,086 shares traded.

Aehr Test Systems News Summary

Here are the key news stories impacting Aehr Test Systems this week:

Analysts Set New Price Targets

AEHR has been the topic of several research reports. Weiss Ratings upgraded Aehr Test Systems from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, May 4th. Craig Hallum upgraded Aehr Test Systems from a “hold” rating to a “buy” rating and set a $68.00 target price for the company in a research report on Wednesday, April 8th. Wall Street Zen upgraded Aehr Test Systems from a “strong sell” rating to a “sell” rating in a report on Saturday, June 6th. Finally, Lake Street Capital reissued a “buy” rating on shares of Aehr Test Systems in a research report on Wednesday. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $68.00.

Get Our Latest Research Report on AEHR

Aehr Test Systems Stock Performance

The company’s fifty day moving average price is $94.74 and its 200 day moving average price is $60.53. The firm has a market capitalization of $2.90 billion, a price-to-earnings ratio of -247.21 and a beta of 3.17.

Insider Activity at Aehr Test Systems

In other news, Director Fariba Danesh sold 8,000 shares of the company’s stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $82.63, for a total transaction of $661,040.00. Following the completion of the transaction, the director directly owned 13,143 shares of the company’s stock, valued at approximately $1,086,006.09. This represents a 37.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Alberto Salamone sold 15,000 shares of the stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $89.57, for a total value of $1,343,550.00. Following the sale, the executive vice president owned 63,025 shares in the company, valued at $5,645,149.25. The trade was a 19.22% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 121,706 shares of company stock valued at $10,832,787. 6.80% of the stock is owned by insiders.

Institutional Investors Weigh In On Aehr Test Systems

Several institutional investors have recently bought and sold shares of the stock. Royal Bank of Canada raised its position in shares of Aehr Test Systems by 262.7% during the 1st quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock worth $365,000 after buying an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Aehr Test Systems by 8.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock valued at $126,000 after acquiring an additional 1,344 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Aehr Test Systems by 7.9% in the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after acquiring an additional 1,145 shares in the last quarter. Legal & General Group Plc increased its stake in shares of Aehr Test Systems by 110.8% during the second quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after acquiring an additional 3,617 shares during the period. Finally, Rhumbline Advisers increased its stake in shares of Aehr Test Systems by 3.1% during the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after acquiring an additional 1,254 shares during the period. Institutional investors and hedge funds own 69.69% of the company’s stock.

Aehr Test Systems Company Profile

(Get Free Report)

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

Recommended Stories

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.